MedPath

Effects of dietary pork intake on serum irisin levels in people with type 2 diabetes

Not Applicable
Conditions
Serum irisin levels in adults with type 2 diabetics.
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12614000840684
Lead Sponsor
Dr. Brendan Plunkett
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Aged 18 to 60 years, clinically diagnosed with type 2 diabetes, regular consumers of meat other than pork in their habitual diet, consuming no more than one pork meal per week and unlikely to change medication/supplement use during the 4-week dietary intervention period.

Exclusion Criteria

Gestational diabetes, insulin dependent, active hepatitis/liver cirrhosis, chronic renal faliure on hemodialysis, congestive heart failure, any other major illnesses or diseases, smokers or currently on nicotine therapy, pregnant or breast feeding women, unwilling or unable to provide a fasting blood sample, unwilling or unable to maintain pre-enrollment habitual dietary and physical activity habits for the duration of the intervention.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum irisin concentration by competitive ELISA analysis[Baseline and at 4 weeks post-intervention]
Secondary Outcome Measures
NameTimeMethod
Fasting blood glucose levels by measured by Hunter Area Pathology Services.[Baseline and at 4-weeks post-intervention];Fasting insulin levels by measured by Hunter Area Pathology Services.[Baseline and at 4-weeks post-intervention];Blood lipid profile (total cholesterol, triglycerides, HDL and LDL cholesterol) measured by Hunter Area Pathology Services.[Baseline and at 4-weeks post-intervention];HOMA index measured by Hunter Area Pathology Services.[Baseline and at 4-weeks post-intervention];Body composition measured by InBody Body Composition Analyser[Baseline and at 4-weeks post-intervention]
© Copyright 2025. All Rights Reserved by MedPath